Prenetics
@Prenetics
Followers
1K
Following
73
Media
55
Statuses
630
Enhancing Life Through Science.
Hong Kong
Joined October 2014
Our hearts are with Tai Po. We’re donating HK$500,000 to the “Support Fund for Wang Fuk Court in Tai Po”. We stand in solidarity with our community, extend our deepest condolences to all who are grieving, and invite those who can to support relief efforts.
1
0
9
I increased my personal ownership in Prenetics with 40,118 shares (US$502K) purchased in the open market. Our full C-suite invested US$1.45M together. We’re aligned with shareholders and confident in IM8’s and our Bitcoin strategy’s long-term trajectory.
6
3
26
Prenetics $48M Post-IPO Round⚡️ 📑 About: @Prenetics is a health-sciences company. 🤝 Investors: Kraken, DL Holdings, Exodus, XtalPi, and others. 👉 https://t.co/05Qo8pfWtc
0
7
47
0-100m ARR in 11 months, fastest growing supplements brand outpacing AI companies like Cursor and Perplexity Ever heard of Prenetics? They were known for DNA tests like CircleDNA you spit in a tube, and they tell you your health risks and family history. They’ve officially
6
1
44
8/8 🧵The plan is simple and measurable: $180–200M FY-2026, and a path to $1B ARR by 2030 through focused product extensions and geographic expansion. TL;DR: repeatable product, improving economics, strong runway = real optionality to win.
0
0
5
7/8 🧵 We’re global by design: 420K+ customer purchases across 41 countries, with 56.5% of revenue outside the U.S. Add David Beckham as co-founder, Aryna Sabalenka’s authentic partnership and investment, a world-class scientific advisory board, and an unconventional Bitcoin
1
0
3
6/8 🧵 Scale needs runway. We have it: $82M cash + 387 BTC (~$40M) ≈ $122M liquid assets, zero debt, and the $44M October raise. That balance sheet gives optionality to invest aggressively while competitors get cautious.
1
0
1
5/8 🧵 The unit economics tell the compounding story: ~80% subscription, ~60% gross margin, 3.9-month payback. Adjusted EBITDA moved from roughly $6M (Q1) → $4M (Q2) → $2.1M (Q3), improving fast while we scale. That’s why we can afford to double down.
1
0
1
4/8 🧵 The growth was healthy and broad. Q3 ended with $6.6M monthly revenue, $17.2M quarterly revenue, 160K+ orders, and 4.8M+ servings delivered. Synchronized gains across acquisition, delivery, and repeat use, not a one channel spike.
1
0
1
3/8 🧵We built momentum off a single, obsessively-refined SKU: Daily Ultimate Essentials. That discipline paid off when Daily Ultimate Longevity launched in October and customers began upgrading: AOV climbed to $150. Product quality created the pull
1
0
1
2/8 🧵 Three levers powered the ramp: • Product rigor: clinical testing, NSF third-party verification and an obsessive focus on formulation gave customers confidence • Subscription-first economics: high subscription rates and rising AOV created predictable, compounding revenue
1
0
1
1/8 🧵 What if one product could rewrite the rules for building a global consumer brand? We launched a science-first supplement at $581K/mo and 11 months later it hit ~$9M/mo, the fastest growth in industry history. How did we do it? Read on.
1
2
10
Q3 results are in and here are the highlights: – We're growing at unprecedented speed. PRE revenue up 568% YoY to $23.6M - IM8: From $0 to $120M ARR in just 12 months - fastest supplement brand growth in industry history globally. – Clear path to scale. Projects $180-200M FY
13
7
80
JUST IN: $PRE Q325 Earnings 📈 Revenue +568% YoY to $23.6M 💪 IM8 hit $9M Oct. revenue, tracking $120M ARR by Dec - the fastest growing supplement brand ever 💰 36% MoM growth, ~80% subscription rates, $150 AOV, ~60% gross margin, payback 3.9 months - category leading unit
1
2
12
LIVE NOW: $PRE Q325 Earnings Conference Call https://t.co/r0q0JdgUQB
1
0
6